ALIM — Alimera Sciences Share News
0.000.00%
Last trade - 00:00- $301.29m
- $360.44m
- $80.75m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:58 PM
Brief: Alimera Sciences Announces Q2 Results
Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview
Brief: Alimera Sciences And Tanner Pharma Group Initiate Global Named Patient Program For Iluvien
Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview
Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview
Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview
Alimera Sciences Inc expected to post earnings of $1.06 a share - Earnings Preview
Alimera Sciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Alimera Sciences Announces Q1 2021 Financial Results
Alimera Sciences Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Ocumension Therapeutics' Unit And Alimera Entered Into Exclusive License Agreement
U.S. STOCKS ON THE MOVE-American Airlines, ATyr, Exact Sciences, SOS
Alimera Sciences: Rises on license agreement, investment from Ocumension Therapeutics
Brief: Alimera Sciences Receives $20 Million From Ocumension Therapeutics
NASDAQ RESUMED AT 09:20 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:25 AM
U.S. RESEARCH ROUNDUP- Editas Medicine, HP, LivePerson
Brief: Alimera Sciences Reports Fourth Quarter And 2020 Results